| Financial Year |
March 31 2023 |
| Monetary Funds |
47,400,227.99 |
| Held-for-trading Financial Assets |
75,127,747.94 |
| Notes Receivable |
300,000.00 |
| Accounts Receivable |
228,975,183.79 |
| Advances to Suppliers |
30,595,396.82 |
| Other Receivables |
13,638,745.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
252,730,397.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,904,037.17 |
| Total Current Assets |
693,621,434.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
300,396,108.87 |
| Under-construction Projects |
2,059,245.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
64,888,267.39 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,438,541.09 |
| Deferred Income Tax Assets |
9,387,988.13 |
| Other Non-Current Assets |
76,965,061.26 |
| Sub-Total of Non-Current Assets |
458,870,005.92 |
| Total Assets |
1,152,491,440.41 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
53,711,318.68 |
| Accounts Payable |
61,694,172.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,208.74 |
| Taxes Payable |
3,042,218.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
293,816.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
458,928.09 |
| Other Current Liabilities |
1,174,633.72 |
| Sub-Total of Current Liabilities |
129,432,434.76 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,518,927.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,687,948.46 |
| Total Liabilities |
145,120,383.22 |
| Paid-In Capital(Or Share Stock) |
167,681,080.00 |
| Capital Surplus |
123,829,628.91 |
| Surplus Reserve |
83,840,540.00 |
| LESS:Treasury Stock |
14,642,211.82 |
| Undistributed Profits |
642,274,601.75 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,007,371,057.19 |
| Owner's Equity（Stockholder's Equity） |
1,007,371,057.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,152,491,440.41 |
